Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
Baert F, Glorieus E, Reenaers C, D'Haens G, Peeters H, Franchimont D, Dewit O, Caenepeel P, Louis E, Van Assche G; BIRD (Belgian IBD Research and Development). Baert F, et al. Among authors: reenaers c. J Crohns Colitis. 2013 Mar;7(2):154-60. doi: 10.1016/j.crohns.2012.03.018. Epub 2012 Apr 24. J Crohns Colitis. 2013. PMID: 22537637
Infliximab and the bone in Crohn's disease.
Franchimont N, Reenaers C, Louis E. Franchimont N, et al. Among authors: reenaers c. Aliment Pharmacol Ther. 2005 Apr 1;21(7):918-9. doi: 10.1111/j.1365-2036.2005.02434.x. Aliment Pharmacol Ther. 2005. PMID: 15801928 Free article. No abstract available.
Does the behavior of Crohn's disease change over time?
Louis E, Reenaers C, Belaiche J. Louis E, et al. Among authors: reenaers c. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S54-5. doi: 10.1002/ibd.20561. Inflamm Bowel Dis. 2008. PMID: 18816690 Free article. No abstract available.
100 results